Specialty Oncology
-
Featured
Biomarkers of T Cell Exhaustion in Checkpoint Inhibitor Therapy
Could altering the balance between two CD8+ T cell states enhance immunotherapies? Research from the Massachusetts General Hospital Cancer Center seeks to find the answer.
-
Tumor Suppressor Gene PBRM1 Frequently Inactivated in Papillary Meningioma
The discovery of a frequent PBRM1 mutation in papillary meningioma suggests a potential new approach to developing therapies for this malignant, aggressive tumor.
-
Psychosocial Intervention Promising for Caregivers of Patients Undergoing Stem Cell Transplantation
In a randomized, controlled trial conducted by the Mass General Cancer Center, a psychosocial intervention for caregivers of patients scheduled to undergo hematopoietic stem cell transplantation was feasible and showed promise for improving caregiving burden, quality of life, mood, self-efficacy and coping skills.
-
Sulfur-metabolizing Bacteria Linked to Increased Risk of Colorectal Cancer
Long-term adherence to a dietary pattern associated with sulfur-metabolizing bacteria in stool is associated with increased risk of distal colon and rectal cancer, according to data from the Health Professionals Follow-up Study.
-
Gene Fusions Detected in Plasma of Glioblastoma Patients, Suggesting New Approach to Liquid Biopsy
A liquid biopsy based on RNA sequencing was feasible for profiling transcriptome-level gene fusions in extracellular vesicles derived from the plasma of patients with glioblastoma.
-
Is There a Connection Between Blood Type and COVID-19? Q&A with Rebecca Karp Leaf, MD, and Hanny Al-Samkari, MD
In this Q&A, Rebecca Karp Leaf, MD, and Hanny Al-Samkari, MD, of Massachusetts General Hospital, give us a rundown of what is known to date about the correlation between blood type and COVID-19 transmission/severity, findings from their study and why this connection may or may not exist.
Oncology contributors
-
Andrew T. Chan, MD, MPH
Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Sulfur-metabolizing Bacteria Linked to Increased Risk of Colorectal Cancer
-
David M. Langenau, PhD
Associate Professor of Pathology, Harvard Medical School, Associate Chair for Research, Department of Pathology, Massachusetts General Hospital
-
J. Keith Joung, MD, PhD
Professor of Pathology, Harvard Medical School, Center for Cancer Research, Desmond and Ann Heathwood MGH Research Scholar
Recent Article
CRISPR Base Editors Can Induce Wide-Ranging Off-Target Edits in RNA
-
Joseph H. Schwab, MD
Chief, Orthopaedic Spine Surgery, Director, Spine Oncology & Co-Director, Stephen L. Harris Chordoma Center, Associate Professor of Orthopedic Surgery, Harvard Medical School
Recent Article
Natural Language Processing Useful for Surveillance of Infections After Spine Surgery
-
Keith T. Flaherty, MD
Director of Clinical Research, Mass General Cancer Center, Professor of Medicine, Harvard Medical School
Recent Article
Medical Grand Rounds: Advancing New Therapies for COVID-19: Antiviral, Immunomodulation and Beyond
-
Marcela G. del Carmen, MD
Chief Medical Officer, Massachusetts General Physicians Organization, Gynecologic Oncologist, Center for Gynecologic Oncology
Recent Article
Editorial: It's Time to Study "Hospital at Home" After Surgery
-
Marcela V. Maus, MD, PhD
Director, Cellular Immunotherapy Program, Mass General Cancer Center, Assistant Professor of Medicine, Harvard Medical School
Recent Article
New Approach to CAR T-Cell Therapy for Glioblastoma Aims to Circumvent Antigen Escape -
Nir Hacohen, PhD
Director, MGH Center for Cancer Immunology
Center for Cancer Research , Professor of Medicine, Harvard Medical School, Senior Member, Broad InstituteRecent Article
Biomarkers of T Cell Exhaustion in Checkpoint Inhibitor Therapy
-
Raul Mostoslavsky, MD, PhD
Laurel Schwartz Professor of Medicine in the Field of Oncology, Mass General Cancer Center, Center for Cancer Research
Recent Article
Inactivating Mutation in the Histone Deacetylase SIRT6 Discovered to Be a Cause of Fetal Demise
-
Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Recent Article
Developing Precision Therapies for Ovarian Cancer
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
Endonasal Surgery Using High-Speed Drill Puts Health Care Team at Risk of COVID-19
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
